<DOC>
	<DOC>NCT00693680</DOC>
	<brief_summary>Examination of the effect of zinc supplementation on imipramine therapy in major depression.</brief_summary>
	<brief_title>Zinc Supplementation of Imipramine Therapy</brief_title>
	<detailed_description>A placebo-controlled, double blind study of zinc supplementation in imipramine therapy was conducted in sixty, depressed patients fulfilling the DSM-IV criteria for major depression without psychotic symptoms. After a one week washout period, patients were randomized into two groups treated with imipramine and receiving once daily either placebo (n=30) or zinc supplementation (n=30) for 12 weeks.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Imipramine</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>patients with fulfilled DSMIV criteria for moderate or severe depressive episode one week washout period without any pharmacotherapy psychotic symptoms</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>depression</keyword>
	<keyword>antidepressant treatment</keyword>
	<keyword>zinc</keyword>
	<keyword>placebo</keyword>
</DOC>